文献速递泌尿生殖与妇科肿瘤放疗

中危前列腺癌咨询前患者教育工具的真实世界实施

Real-world implementation of a pre-consultation patient educational tool for intermediate risk prostate cancer.
PubMed 文献 · Clin Transl Radiat Oncol · 2026-07-10

本研究开发并自动分发基于通俗语言和循证内容的前列腺癌教育工具给新诊断中危前列腺癌患者,395例患者接收,79.7%完成问卷。结果显示88.1%受访者感觉与医疗团队讨论更有准备,74.8%表示对诊断理解提高,93.9%推荐该工具;探索性分析显示实施前后序贯队列的治疗选择有统计学显著差异(p=0.048),近距离放疗和局灶治疗选择略有增加。

要点

  • 教育工具自动分发可行,79.7%患者完成使用后问卷。
  • 88.1%受访者感觉与医疗团队讨论更有准备,93.9%推荐该工具。
  • 探索性分析显示实施前后治疗选择有显著差异(p=0.048)。

核心结论

  • 前列腺癌教育工具提高了患者对诊断的理解和咨询准备度,并可能影响治疗选择。

研究设计与样本

  • 单中心真实世界实施研究,开发基于通俗语言和循证内容的教育工具并自动分发给新诊断中危前列腺癌患者,通过使用后问卷评估,并比较实施前后序贯队列的治疗选择。

主要发现

  • 共395例患者接收工具,79.7%完成问卷;88.1%受访者感觉与医疗团队讨论更有准备,74.8%表示对诊断理解提高,93.9%推荐该工具。
  • 定性分析显示患者对工具全面性和格式有正面反馈,同时指出改进领域。
  • 探索性比较显示序贯队列间治疗选择有统计学显著差异(p=0.048),近距离放疗和局灶治疗选择略有增加。

关键数值与推荐

  • 问卷完成率79.7%(395例接收者中)。
  • 88.1%受访者感觉更有准备与医疗团队讨论。
  • 74.8%受访者表示对诊断理解提高。
  • 93.9%受访者推荐该工具给其他患者。
  • 序贯队列治疗选择差异p=0.048。

临床怎么用

  • 可在临床工作流中自动分发教育工具,以提升中危前列腺癌患者的咨询准备度和诊断理解。
  • 工具使用可能与治疗选择变化相关,但需进一步研究确认因果关系。

局限性

  • 探索性分析,治疗选择差异需谨慎解读。
  • 单中心真实世界研究,结果外推性有限。
  • 未报告问卷未完成者的特征及可能的选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Prostate Cancer (PCa) decision-making requires patients to understand their diagnosis and therapeutic options, balancing care nuances and risk-to-benefit profiles. The complexity of information and a wide range of treatments often exceed what can be covered in consultation. Our team developed a PCa Educational Tool to enhance patient understanding and support decision-making process. METHODS: The PCa Educational Tool was designed using plain language principles and evidence-based content. The tool was distributed automatically to newly diagnosed intermediate-risk PCa patients. A post-use questionnaire assessed usability, satisfaction, and perceived educational value. Qualitative feedback was categorized by sentiment and themes. Treatment selection was explored between sequential cohorts before and after implementation. RESULTS: A total of 395 patients received the tool, and 79.7% completed the questionnaire. Among respondents, 88.1% felt more prepared for discussion with their care team, and 74.8% indicated improved understanding of their diagnosis. Satisfaction rates were high, with 93.9% of respondents recommending the tool to other patients. Qualitative analysis revealed positive feedback on the tool's comprehensiveness and format, while highlighting other areas for improvement. Exploratory comparison of treatment selection showed statistically significant differences between the sequential cohorts, with a slight increase selection of brachytherapy and focal therapies. CONCLUSIONS: PCa Educational Tool improved patient understanding and preparedness for consultation with the care team. In exploratory analysis, its use is correlated with a statistically significant shift in treatment choices in sequential cohorts (p = 0.048). The process was automated and proved to seamlessly integrate into our clinical workflow. Future steps include tool refinement based on patient feedback.

来源:Clin Transl Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Borras-Osorio M, Kowalchuk RO, Preston HR, et al. Real-world implementation of a pre-consultation patient educational tool for intermediate risk prostate cancer. Clin Transl Radiat Oncol. 2026. PMID: 42519504. doi:10.1016/j.ctro.2026.101224

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。